Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres.
Saved in:
| Title: | Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres. |
|---|---|
| Authors: | Shim, Jin-Kyoung1,2 (AUTHOR), Choi, Seonah1 (AUTHOR), Yoon, Seon-Jin1,2 (AUTHOR), Choi, Ran Joo1,2 (AUTHOR), Park, Junseong1,2,3 (AUTHOR), Lee, Eun Hee1,2 (AUTHOR), Cho, Hye Joung1,2 (AUTHOR), Lee, Suji4 (AUTHOR), Teo, Wan-Yee5,6 (AUTHOR), Moon, Ju Hyung1 (AUTHOR), Kim, Hyun Sil7 (AUTHOR), Kim, Eui Hyun1,2 (AUTHOR), Cheong, Jae-Ho8 (AUTHOR), Chang, Jong Hee1 (AUTHOR), Yook, Jong In7 (AUTHOR), Kang, Seok-Gu1,2,9 (AUTHOR) seokgu9@gmail.com |
| Source: | Cancer Cell International. 10/11/2022, Vol. 22 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14752867 |
|---|---|
| DOI: | 10.1186/s12935-022-02731-7 |
